EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hepatitis B reactivation following switch away from tenofovir-containing anti-retroviral therapy in people living with HIV: A case series and lessons for practice

Flora Olcott iD, Philip D Oddie iD, Maeve J Barlow iD, Athanasios Mamarelis iD, Matthew Byott iD, Paul Grant iD, Johannes Botha iD, Clare Booth iD, Laura Waters iD, Philippa C Matthews iD, Stuart Flanagan iD, Eleni Nastouli iD und 1 weitere

Clinical Infectious Diseases · 19.11.2025

DOI: 10.1093/cid/ciaf634 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 19.11.2025. Verfasst von Flora Olcott und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Global Health, University College London, London, United Kingdom. Die Arbeit wurde bisher 10-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The potential for hepatitis B reactivation must be considered when switching people with HIV and prior hepatitis B exposure away from tenofovir-containing combined anti-retroviral therapy. Four cases of hepatitis B reactivation from the United Kingdom are presented. Hepatitis B mutations, risk factors and pre- and post-switch recommendations are explored.

Autor:innen und Institutionen

  • Institute for Global Health, University College London, London, United Kingdom.
  • Mortimer Market Clinic, Central and Northwest London NHS Foundation Trust, London, United Kingdom.
  • Mortimer Market Clinic, Central and Northwest London NHS Trust, London, United Kingdom.
  • Department of Infectious Diseases, University College London Hospital NHS Trust, London, United Kingdom.
  • Advanced Pathogen Diagnostic Unit, Virology, University College London Hospital, London, United Kingdom.
  • Health Services Laboratories, The Halo Building, London, United Kingdom.

ORCID-Profile: Flora Olcott, Philip D Oddie, Maeve J Barlow, Athanasios Mamarelis, Matthew Byott, Paul Grant, Johannes Botha, Clare Booth, Laura Waters, Philippa C Matthews, Stuart Flanagan, Eleni Nastouli, Indrajit Ghosh

Zitieren

APA

Olcott, F., Oddie, P. D., Barlow, M. J., Mamarelis, A., Byott, M., Grant, P., Botha, J., Booth, C., Waters, L., Matthews, P. C., Flanagan, S., Nastouli, E., & Ghosh, I. (2025). Hepatitis B reactivation following switch away from tenofovir-containing anti-retroviral therapy in people living with HIV: A case series and lessons for practice. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciaf634

Vancouver

Olcott F, Oddie PD, Barlow MJ, Mamarelis A, Byott M, Grant P, et al. Hepatitis B reactivation following switch away from tenofovir-containing anti-retroviral therapy in people living with HIV: A case series and lessons for practice. Clinical Infectious Diseases. 2025. doi:10.1093/cid/ciaf634

BibTeX
@article{Olcott2025,
  author = {Olcott, Flora and Oddie, Philip D and Barlow, Maeve J and Mamarelis, Athanasios and Byott, Matthew and Grant, Paul and Botha, Johannes and Booth, Clare and Waters, Laura and Matthews, Philippa C and Flanagan, Stuart and Nastouli, Eleni and Ghosh, Indrajit},
  title = {Hepatitis B reactivation following switch away from tenofovir-containing anti-retroviral therapy in people living with HIV: A case series and lessons for practice},
  journal = {Clinical Infectious Diseases},
  year = {2025},
  doi = {10.1093/cid/ciaf634}
}
Kostenlos starten →